Please assess the completion status of the following clinical trial:

Trial Title: Detection of miRNAs in HPA Axis Function in Healthy Subjects

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adults age ≥ 18~Exclusion Criteria:~* Pregnancy~* Presence of a disease that affects HPA axis function~* Current use of medications that affect cortisol secretion, such as opioid pain medication, anti-fungal agents, anti-epileptic agents, and glucocorticoids, including hydrocortisone, prednisone, dexamethasone, steroid-containing inhalers, and steroid injected into the joints~* History of adverse event related to use of glucocorticoids

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Dexamthesone (Type: EXPERIMENTAL): Single arm study in which all healthy controls will receive 1 mg of dexamethasone intravenous (IV) injection.

Based on this trial design, predict the completion outcome and termination type (if applicable).